Evidence map›Paper›PMID 26801062›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2016

Circulating soluble receptor for advanced glycation end products is decreased and inversely associated with acute phase response in chronic spontaneous urticaria.

A Kasperska-Zajac, A Damasiewicz-Bodzek, K Tyrpień-Golder, J Zamlyński, A Grzanka

Abstract read
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A Kasperska-ZajacDepartment of Internal Diseases, Dermatology and Allergology in Zabrze, SMDZ in Zabrze, Medical University of Silesia in Katowice, ul. M. Curie-Skłodowskiej 10, 41-800, Zabrze, Poland. alakasperska@gmail.com.
A Damasiewicz-BodzekDepartment of Chemistry in Zabrze, SMDZ in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.
K Tyrpień-GolderDepartment of Chemistry in Zabrze, SMDZ in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.
J ZamlyńskiDepartment of Gynaecology, Obstetrics and Oncological Gynaecology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.
A GrzankaDepartment of Internal Diseases, Dermatology and Allergology in Zabrze, SMDZ in Zabrze, Medical University of Silesia in Katowice, ul. M. Curie-Skłodowskiej 10, 41-800, Zabrze, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActivation of receptor for advanced glycation end products (RAGE) leads to the proinflammatory response and the release of its soluble form (sRAGE) which appears to function as an anti-inflammatory feedback mechanism.

aimTo determine serum sRAGE concentration in CSU patients and its association with C-reactive protein (CRP) concentration, a nonspecific inflammatory marker of the disease activity.

methodsConcentrations of sRAGE and CRP were measured in serum of CSU patients and compared with the healthy controls.

resultsSerum sRAGE concentrations were significantly decreased in CSU patients, especially those more severely affected. In addition, significant inverse correlations were observed between sRAGE and CRP concentrations.

conclusionsDown-regulation of sRAGE and its association with acute phase response suggest a role for RAGE activation in the pathogenesis of CSU. It seems that lower serum sRAGE concentration may enhance the urticarial processes.

Indexed as

Acute-Phase ReactionAdultChronic DiseaseC-Reactive ProteinFemaleHumansMaleMiddle AgedReceptor for Advanced Glycation End ProductsSeverity of Illness IndexSkin TestsUrticariaC-Reactive ProteinReceptor for Advanced Glycation End ProductsAcute phase responseChronic spontaneous urticariaC-reactive proteinSoluble receptor for advanced glycation end products

Identifiers

PMID26801062
PMCPMC4823317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.